
( (S 
    (NP-SBJ 
      (NP 
        (NP (NNP Lyphomed) (NNP Inc.) )
        (, ,) 
        (NP 
          (NP (NNP Rosemont) )
          (, ,) 
          (NP (NNP Ill.) ))
        (, ,) )
      (CC and) 
      (NP 
        (NP (NNP Medco) (NNP Research) (NNP Inc.) )
        (, ,) 
        (NP (NNP Los) (NNP Angeles) )
        (, ,) ))
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NNP Food) 
            (CC and)
            (NNP Drug) (NNP Administration) )
          (VP (VBD granted) 
            (NP 
              (NP (JJ full) (NN marketing) (NN approval) )
              (PP (IN for) 
                (NP 
                  (NP (DT a) (JJ new) (NN drug) )
                  (PP (IN for) 
                    (NP 
                      (NP (DT the) (NN treatment) )
                      (PP (IN of) 
                        (NP 
                          (NP (DT a) (NN condition) )
                          (SBAR 
                            (WHPP-1 (IN in) 
                              (WHNP (WDT which) ))
                            (S 
                              (NP-SBJ (DT the) (NN heart) )
                              (VP (VBZ beats) 
                                (NP 
                                  (NP 
                                    (QP (IN between) (CD 150) 
                                      (CC and)
                                      (CD 200) )
                                    (NNS beats) )
                                  (NP-ADV (DT a) (NN minute) ))
                                (PP-LOC (-NONE- *T*-1) )))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NN condition) )
      (, ,) 
      (VP (VBN known) 
        (NP (-NONE- *) )
        (PP-CLR (IN as) 
          (NP (JJ paroxysmal) (JJ supraventricular) (NN tachycardia) )))
      (, ,) )
    (VP (VBZ leads) 
      (PP-CLR (TO to) 
        (NP (NN dizziness) 
          (CC and)
          (NN fainting) )))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (JJ typical) (JJ healthy) (NN heart) )
    (VP (VBZ beats) 
      (NP 
        (NP (CD 70) (NNS times) )
        (NP-ADV (DT a) (NN minute) )))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NN drug) )
      (, ,) 
      (VP (VBN called) 
        (S 
          (NP-SBJ (-NONE- *) )
          (NP-PRD (NN adenocard) )))
      (, ,) )
    (VP (VBZ returns) 
      (NP (DT the) (NN heart) )
      (PP-CLR (TO to) 
        (NP (DT a) (JJ normal) (NN rhythm) ))
      (PP-TMP (IN within) 
        (NP (NNS seconds) ))
      (, ,) 
      (PP (VBG according) 
        (PP (TO to) 
          (NP (NNP Lyphomed) ))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Medco) (NNP Research) )
    (VP 
      (VP (VBD developed) 
        (NP (DT the) (NN drug) ))
      (CC and) 
      (VP (VBD licensed) 
        (NP (PRP it) )
        (PP-CLR (TO to) 
          (NP (NNP Lyphomed) ))
        (PP-CLR (IN for) 
          (NP 
            (NP (NN sale) )
            (PP-LOC (IN in) 
              (NP 
                (NP (DT the) (NNP U.S.) )
                (CC and) 
                (NP (NNP Canada) )))))))
    (. .) ))
